Commentary · 21 Feb 2026
Conference abstractPublished 10 May 2018
Role of mammary gland stem/progenitor cells in tumorigenesis
University of Texas Health Science Center, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Aging is a major risk fact for breast cancer. Recent research implicated that adult mammary stem cells (MaSCs) might be responsible for the initiation and progression of certain types of breast cancer. In this study, MaSC-enriched basal cells were utilized for the evaluation of MaSC frequency and function during aging by in vitro mammosphere formation and 3D-ECM sphere differentiation assays and by in vivo cleared mammary fat pad transplantation (IVT) as we reported recently. We found that the basal-to-luminal cell ratios analyzed with flow cytometry and the frequency of MaSCs analyzed with the in vitro assays increased steadily with increasing age in various strains of mice. Subsequent IVT using mammosphere or 3D-ECM structures formed by young (2-4 months) or old (25-32 months) MaSCs derived from C57BL/6 mice showed that the regenerated glands from old MaSCs had significantly higher number of spontaneous atypical ductal hyperplastic lesions than those from young MaSCs. These findings indicate that aged MaSCs can serve as the cell of origin for early neoplastic transformation in breast tissue. Subsequent whole genome transcriptome analysis with the second generation sequencing revealed age-associated differential expression of genes involved in immune, inflammatory, and wounding responses in both mammosphere-forming cells and stromal cells suggesting that these may be the main cellular processes contributing to the dysfunctional MaSC phenotypes. Consistently, short-term (5-10 days) treatment of old C57BL/6 mice with rapamycin, an antiinflammation drug, reversed phenotypic changes associated with aged mammary gland. Histological analysis of regenerated glands by aged MaSCs derived from control and rapamycin-treated mice showed a significant decrease of early neoplastic lesions in rapamycin-treated group. In conclusion, our findings suggest that aging causes MaSC to form early neoplastic lesions, which can be inhibited by rapamycin treatment.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “LuZhe Sun”
